Literature DB >> 7239515

Structural differences in pericentric inversions. Application to a model of risk of recombinants.

A Daniel.   

Abstract

The potential chromosomal imbalance in offspring of pericentric inversion heterozygotes can be evaluated by measuring (% of haploid autosomal length, % HAL) the chromosomal segments distal to the breakpoints in the inversion. These distal segments were measured in presently reported and published cases of pericentric inversions, divided into two ascertainment groups: (I) those ascertained through recombinant offspring and (II) those ascertained through balanced heterozygotes. The distal segments in group II inversions were significantly larger than those of group I, i.e., the potentially larger chromosomal imbalances were not observed in full-term offspring. These results are discussed in relation to the model of risk of abnormal offspring in the progeny of heterozygotes for structural rearrangements (the chromosome imbalance size--viability model). The mean distal segment sizes for group I and group II pericentric inversions were respectively not significantly different from the mean interchange segment size for a sample of reciprocal translocations divided into the same two ascertainment groups. It was concluded that the restrictions on the size (% HAL) of chromosomal imbalance in offspring surviving until term are similar whether this imbalance arises from reciprocal translocations or pericentric inversions.

Entities:  

Mesh:

Year:  1981        PMID: 7239515     DOI: 10.1007/bf00274687

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Cytological assessment of meiotic exchange in a human male with a pericentric inversion of chromosome No. 4.

Authors:  A G Van der Linden; P L Pearson; J J Van de Kamp
Journal:  Cytogenet Cell Genet       Date:  1975

2.  Inherited partial duplication of chromosome No. 15.

Authors:  A Fujimoto; J W Towner; A J Ebbin; E J Kahlstrom; M G Wilson
Journal:  J Med Genet       Date:  1974-09       Impact factor: 6.318

3.  Precise identification of various chromosomal abnormalities.

Authors:  K Hirschhorn; M Lucas; I Wallace
Journal:  Ann Hum Genet       Date:  1973-04       Impact factor: 1.670

4.  Down's syndrome with an atypical G-G translocation derived from familial pericentric inversion in one chromosome of the G group.

Authors:  S Morić-Petrović; Z Laća; P Kalicanin
Journal:  J Med Genet       Date:  1972-12       Impact factor: 6.318

5.  Inherited pericentric inversion of chromosome number two: a linkage study.

Authors:  L R Weitkamp; M K Janzen; S A Guttormsen; H Gershowitz
Journal:  Ann Hum Genet       Date:  1969-07       Impact factor: 1.670

6.  The consequences of crossing-over in pericentric inversions in acrocentric chromosomes.

Authors:  P E Brandham
Journal:  Heredity (Edinb)       Date:  1970-02       Impact factor: 3.821

7.  Structural differences in reciprocal translocations. Potential for a model of risk in Rcp.

Authors:  A Daniel
Journal:  Hum Genet       Date:  1979-10-01       Impact factor: 4.132

8.  Two pericentric inversions of human chromosome 11.

Authors:  K Simola; P Karli; A De La Chapelle
Journal:  J Med Genet       Date:  1977-10       Impact factor: 6.318

9.  Chromosome 3 duplication q21 leads to qter deletion p25 leads to pter syndrome in children of carriers of a pericentric inversion inv(3) (p25q21).

Authors:  P W Allderdice; N Browne; D P Murphy
Journal:  Am J Hum Genet       Date:  1975-11       Impact factor: 11.025

10.  Inherited pericentric inversion of chromosome no. 2 with Robertsonian translocation (13q 14q) resulting in trisomy for chromosome 13q.

Authors:  R S Verma; H Dosik; I B Wexler
Journal:  J Genet Hum       Date:  1977-12
View more
  16 in total

1.  A malformed child with a recombinant chromosome 7, rec(7) dup p, derived from a maternal pericentric inversion inv(7)(p15q36).

Authors:  A Delicado; E Escribano; I Lopez Pajares; A Diaz de Bustamante; S Carrasco
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

2.  Unusual segregation products in sperm from a pericentric inversion 17 heterozygote.

Authors:  Monica M Mikhaail-Philips; Barbara C McGillivray; Sara J Hamilton; Evelyn Ko; Judy Chernos; Alfred Rademaker; Renée H Martin
Journal:  Hum Genet       Date:  2005-05-28       Impact factor: 4.132

3.  Molecular analysis of recombination in a family with Duchenne muscular dystrophy and a large pericentric X chromosome inversion.

Authors:  V Shashi; W L Golden; P S Allinson; S H Blanton; C von Kap-Herr; T E Kelly
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  On the significance of pericentric inversions of chromosome 2.

Authors:  J Wahlström; M Kyllerman
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

5.  Genetic risk for recombinant 8 syndrome and the transmission rate of balanced inversion 8 in the Hispanic population of the southwestern United States.

Authors:  A C Smith; K Spuhler; T M Williams; T McConnell; E Sujansky; A Robinson
Journal:  Am J Hum Genet       Date:  1987-12       Impact factor: 11.025

6.  Paternal pericentric inversion of chromosome 4 as a cause of recurrent pregnancy loss.

Authors:  G C Wolf; J Mao; L Izquierdo; G Joffe
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

7.  Familial inv(1) (p3500q21.3) associated with azoospermia.

Authors:  H Rivera; M C Alvarez-Arratia; M Moller; M Díaz; J M Cantú
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 8.  Aspects of evaluation, significance, and evolution of human C-band heteromorphism.

Authors:  B Erdtmann
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Pericentric inversion of chromosome 1 in an azoospermic man.

Authors:  A Tóth; M Gaál; G Sára; J László
Journal:  J Med Genet       Date:  1982-08       Impact factor: 6.318

Review 10.  Pericentric inversions. Problems and significance for clinical genetics.

Authors:  P Kaiser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.